{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:42:30Z","timestamp":1785883350178,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/L014904\/1"],"award-info":[{"award-number":["EP\/L014904\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000364","name":"Stroke Association","doi-asserted-by":"publisher","award":["TSA 2017\/03"],"award-info":[{"award-number":["TSA 2017\/03"]}],"id":[{"id":"10.13039\/501100000364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mesenchymal stem cells (MSCs) hold great potential as a therapy for stroke and have previously been shown to promote recovery in preclinical models of cerebral ischaemia. MSCs secrete a wide range of growth factors, chemokines, cytokines and extracellular vesicles\u2014collectively termed the secretome. In this study, we assessed for the first time the efficacy of the IL-1\u03b1-primed MSC-derived secretome on brain injury and functional recovery after cerebral ischaemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Stroke was induced in male C57BL\/6 mice using the intraluminal filament model of middle cerebral artery occlusion. Conditioned medium from IL-1\u03b1-primed MSCs or vehicle was administered at the time of reperfusion or at 24\u2009h post-stroke by subcutaneous injection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>IL-1\u03b1-primed MSC-derived conditioned medium treatment at the time of stroke led to a ~\u200930% reduction in lesion volume at 48\u2009h and was associated with modest improvements in body mass gain, 28-point neurological score and nest building. Administration of MSC-derived conditioned medium at 24\u2009h post-stroke led to improved nest building and neurological score despite no observed differences in lesion volume at day 2 post-stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results show for the first time that the administration of conditioned medium from IL-1\u03b1-primed MSCs leads to improvements in behavioural outcomes independently of neuroprotection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-020-1560-y","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T17:03:10Z","timestamp":1579626190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke"],"prefix":"10.1186","volume":"11","author":[{"given":"Catriona J.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Barrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Tamburrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Pinteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-4456","authenticated-orcid":false,"given":"Stuart M.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"1560_CR1","volume-title":"Global status report on noncommunicable diseases","author":"World Health Organisation","year":"2014","unstructured":"World Health Organisation. Global status report on noncommunicable diseases 2014., https:\/\/www.cabdirect.org\/cabdirect\/abstract\/20153093363 (2014, Accessed 25 Mar 2019)."},{"key":"1560_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","volume":"383","author":"VL Feigin","year":"2014","unstructured":"Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990\u20132010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383:245\u201355.","journal-title":"Lancet"},{"key":"1560_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fneur.2019.00405","volume":"10","author":"N Satani","year":"2019","unstructured":"Satani N, Cai C, Giridhar K, et al. World-wide efficacy of bone marrow derived mesenchymal stromal cells in preclinical ischemic stroke models: systematic review and meta-analysis. Front Neurol. 2019;10:405.","journal-title":"Front Neurol"},{"key":"1560_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.46582\/jsrm.1301003","volume":"13","author":"A Bhasin","year":"2017","unstructured":"Bhasin A, Kumaran SS, Bhatia R, et al. Safety and feasibility of autologous mesenchymal stem cell transplantation in chronic stroke in Indian patients. A four-year follow up. J Stem Cells Regen Med. 2017;13:14\u20139.","journal-title":"J Stem Cells Regen Med"},{"key":"1560_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1161\/STROKEAHA.116.012995","volume":"47","author":"GK Steinberg","year":"2016","unstructured":"Steinberg GK, Kondziolka D, Wechsler LR, et al. Clinical outcomes of transplanted modified bone marrow\u2013derived mesenchymal stem cells in stroke: a phase 1\/2a study. Stroke. 2016;47:1817\u201324.","journal-title":"Stroke"},{"key":"1560_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0022-510X(01)00557-3","volume":"189","author":"J Chen","year":"2001","unstructured":"Chen J, Li Y, Wang L, et al. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci. 2001;189:49\u201357.","journal-title":"J Neurol Sci"},{"key":"1560_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/01.STR.32.4.1005","volume":"32","author":"J Chen","year":"2001","unstructured":"Chen J, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005\u201311.","journal-title":"Stroke"},{"key":"1560_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/0271678X18776802","volume":"38","author":"CJ Cunningham","year":"2018","unstructured":"Cunningham CJ, Redondo-castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38:1276\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1560_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5966\/sctm.2015-0078","volume":"4","author":"TR Doeppner","year":"2015","unstructured":"Doeppner TR, Herz J, G\u00f6rgens A, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4:1131\u201343.","journal-title":"Stem Cells Transl Med"},{"key":"1560_CR10","doi-asserted-by":"publisher","first-page":"44433","DOI":"10.1038\/srep44433","volume":"7","author":"L Otero-Ortega","year":"2017","unstructured":"Otero-Ortega L, Laso-Garc\u00eda F, G\u00f3mez-de Frutos MD, et al. White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke. Sci Rep. 2017;7:44433.","journal-title":"Sci Rep"},{"key":"1560_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.brainres.2015.08.003","volume":"1624","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Hu J, Xiang J, et al. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Res. 2015;1624:489\u201396.","journal-title":"Brain Res"},{"key":"1560_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.brainres.2012.04.033","volume":"1461","author":"Y Egashira","year":"2012","unstructured":"Egashira Y, Sugitani S, Suzuki Y, et al. The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res. 2012;1461:87\u201395.","journal-title":"Brain Res"},{"key":"1560_CR13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/jcp.26931","volume":"234","author":"R-H Jiang","year":"2019","unstructured":"Jiang R-H, Wu C-J, Xu X-Q, et al. Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats. J Cell Physiol. 2019;234:1354\u201368.","journal-title":"J Cell Physiol"},{"key":"1560_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2011.05.012","volume":"8","author":"CEP Goldring","year":"2011","unstructured":"Goldring CEP, Duffy PA, Benvenisty N, et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 2011;8:618\u201328.","journal-title":"Cell Stem Cell"},{"key":"1560_CR15","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, Yl\u00f6stalo JH, Mohammadipoor A, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107:13724\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1560_CR16","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678\u201385.","journal-title":"Circ Res"},{"key":"1560_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13287-017-0531-4","volume":"8","author":"E Redondo-Castro","year":"2017","unstructured":"Redondo-Castro E, Cunningham C, Miller J, et al. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther. 2017;8:79.","journal-title":"Stem Cell Res Ther"},{"key":"1560_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"1560_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3995\/jstroke.8.1","volume":"8","author":"J Koizumi","year":"1986","unstructured":"Koizumi J, Yoshida Y, Nakazawa T, et al. Experimental studies of ischemic brain edema, I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the. Japanese J Stroke. 1986;8:1\u20138.","journal-title":"Japanese J Stroke"},{"key":"1560_CR20","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1177\/0271678X17709185","volume":"37","author":"N Percie du Sert","year":"2017","unstructured":"Percie du Sert N, Alfieri A, Allan SM, et al. The IMPROVE guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments). J Cereb Blood Flow Metab. 2017;37:3488\u2013517.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1560_CR21","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1161\/01.STR.29.10.2136","volume":"29","author":"W Clark","year":"1998","unstructured":"Clark W, Gunion-Rinker L, Lessov N, et al. Citicoline treatment for experimental intracerebral hemorrhage in mice editorial comment. Stroke. 1998;29:2136\u201340.","journal-title":"Stroke"},{"key":"1560_CR22","doi-asserted-by":"crossref","unstructured":"Balkaya MG, Trueman RC, Boltze J, et al. Behavioral outcome measures to improve experimental stroke research. Behav Brain Res. 2018;352:161\u201371.","DOI":"10.1016\/j.bbr.2017.07.039"},{"key":"1560_CR23","doi-asserted-by":"crossref","unstructured":"Deacon R. Assessing burrowing, nest construction, and hoarding in mice. J Vis Exp. 2012:e2607.","DOI":"10.3791\/2607"},{"key":"1560_CR24","doi-asserted-by":"crossref","unstructured":"Gaskill BN, Karas AZ, Garner JP, et al. Nest building as an indicator of health and welfare in laboratory mice. J Vis Exp. 2013;51012.","DOI":"10.3791\/51012"},{"key":"1560_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2017.08.019","volume":"658","author":"A Blasco-Serra","year":"2017","unstructured":"Blasco-Serra A, Gonz\u00e1lez-Soler EM, Cervera-Ferri A, et al. A standardization of the novelty-suppressed feeding test protocol in rats. Neurosci Lett. 2017;658:73\u20138.","journal-title":"Neurosci Lett"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2013.06.001","volume":"58","author":"S-W Yoo","year":"2013","unstructured":"Yoo S-W, Chang D-Y, Lee H-S, et al. Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-\u03b2. Neurobiol Dis. 2013;58:249\u201357.","journal-title":"Neurobiol Dis"},{"key":"1560_CR27","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/STROKEAHA.112.677328","volume":"44","author":"S Ishizaka","year":"2013","unstructured":"Ishizaka S, Horie N, Satoh K, et al. Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke. 2013;44:720\u20136.","journal-title":"Stroke"},{"key":"1560_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.brainres.2008.06.087","volume":"1229","author":"S-H Koh","year":"2008","unstructured":"Koh S-H, Kim KS, Choi MR, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008;1229:233\u201348.","journal-title":"Brain Res"},{"key":"1560_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jnr.21056","volume":"84","author":"Y Horita","year":"2006","unstructured":"Horita Y, Honmou O, Harada K, et al. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res. 2006;84:1495\u2013504.","journal-title":"J Neurosci Res"},{"key":"1560_CR30","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awl207","volume":"129","author":"H Liu","year":"2006","unstructured":"Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain. 2006;129:2734\u201345.","journal-title":"Brain"},{"key":"1560_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.jcbfm.9600527","volume":"28","author":"T Onda","year":"2008","unstructured":"Onda T, Honmou O, Harada K, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab. 2008;28:329\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1560_CR32","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s12015-017-9755-z","volume":"3","author":"H Ghazavi","year":"2017","unstructured":"Ghazavi H, Hoseini SJ, Ebrahimzadeh-Bideskan A, et al. Fibroblast growth factor type 1 (FGF1)-overexpressed adipose-derived mesenchaymal stem cells (AD-MSCFGF1) induce neuroprotection and functional recovery in a rat stroke model. Stem Cell Rev Reports. 2017;3:670\u201385.","journal-title":"Stem Cell Rev Reports"},{"key":"1560_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.matbio.2016.01.010","volume":"51","author":"DJ Prockop","year":"2016","unstructured":"Prockop DJ. Inflammation, fibrosis, and modulation of the process by mesenchymal stem\/stromal cells. Matrix Biol. 2016;51:7\u201313.","journal-title":"Matrix Biol"},{"key":"1560_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S0002-9440(10)64964-4","volume":"156","author":"HJH Marti","year":"2000","unstructured":"Marti HJH, Bernaudin M, Bellail A, et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000;156:965\u201376.","journal-title":"Am J Pathol"},{"key":"1560_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-018-1153-1","volume":"15","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Wang L, Qu M, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15:135.","journal-title":"J Neuroinflammation"},{"key":"1560_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneurol.2016.46","volume":"12","author":"JM Ferro","year":"2016","unstructured":"Ferro JM, Caeiro L, Figueira ML. Neuropsychiatric sequelae of stroke. Nat Rev Neurol. 2016;12:269\u201380.","journal-title":"Nat Rev Neurol"},{"key":"1560_CR37","doi-asserted-by":"crossref","unstructured":"Feng C, Fang M, Liu X. The neurobiological pathogenesis of poststroke depression. Sci World J. 2014:521349 http:\/\/www.hindawi.com\/journals\/tswj\/2014\/521349\/abs\/ (Accessed 11 May 2015).","DOI":"10.1155\/2014\/521349"},{"key":"1560_CR38","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/1747493016669861","volume":"11","author":"TB Cumming","year":"2016","unstructured":"Cumming TB, Packer M, Kramer SF, et al. The prevalence of fatigue after stroke: a systematic review and meta-analysis. Int J Stroke. 2016;11:968\u201377.","journal-title":"Int J Stroke"},{"key":"1560_CR39","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.bbi.2007.01.012","volume":"21","author":"JL Teeling","year":"2007","unstructured":"Teeling JL, Felton LM, Deacon RMJ, et al. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun. 2007;21:836\u201350.","journal-title":"Brain Behav Immun"},{"key":"1560_CR40","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1097\/00001756-200107030-00052","volume":"12","author":"R Deacon","year":"2001","unstructured":"Deacon R, Raley J, Perry V, et al. Burrowing into prion disease. Neuroreport. 2001;12:2053\u20137.","journal-title":"Neuroreport"},{"key":"1560_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0166-4328(01)00401-6","volume":"132","author":"RMJ Deacon","year":"2002","unstructured":"Deacon RMJ, Croucher A, Rawlins JNP. Hippocampal cytotoxic lesion effects on species-typical behaviours in mice. Behav Brain Res. 2002;132:203\u201313.","journal-title":"Behav Brain Res"},{"key":"1560_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bbr.2008.09.042","volume":"197","author":"RMJ Deacon","year":"2009","unstructured":"Deacon RMJ, Koros E, Bornemann KD, et al. Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behav Brain Res. 2009;197:466\u20138.","journal-title":"Behav Brain Res"},{"key":"1560_CR43","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RMJ Deacon","year":"2006","unstructured":"Deacon RMJ. Assessing nest building in mice. Nat Protoc. 2006;1:1117\u20139.","journal-title":"Nat Protoc"},{"key":"1560_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jneumeth.2014.02.001","volume":"234","author":"P Jirkof","year":"2014","unstructured":"Jirkof P. Burrowing and nest building behavior as indicators of well-being in mice. J Neurosci Methods. 2014;234:139\u201346.","journal-title":"J Neurosci Methods"},{"key":"1560_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.124","volume":"6","author":"F Vahid-Ansari","year":"2016","unstructured":"Vahid-Ansari F, Lagace DC, Albert PR. Persistent post-stroke depression in mice following unilateral medial prefrontal cortical stroke. Transl Psychiatry. 2016;6:e863.","journal-title":"Transl Psychiatry"},{"key":"1560_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.biopsych.2012.02.026","volume":"72","author":"G Kronenberg","year":"2012","unstructured":"Kronenberg G, Balkaya M, Prinz V, et al. Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry. 2012;72:273\u201381.","journal-title":"Biol Psychiatry"},{"key":"1560_CR47","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.13461","volume":"45","author":"LM Soares","year":"2017","unstructured":"Soares LM, Meyer E, Milani H, et al. The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticity. Eur J Neurosci. 2017;45:510\u201320.","journal-title":"Eur J Neurosci"},{"key":"1560_CR48","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.biopsych.2005.02.010","volume":"57","author":"B Winter","year":"2005","unstructured":"Winter B, Juckel G, Viktorov I, et al. Anxious and hyperactive phenotype following brief ischemic episodes in mice. Biol Psychiatry. 2005;57:1166\u201375.","journal-title":"Biol Psychiatry"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-1560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-1560-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-1560-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:19:34Z","timestamp":1611101974000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-1560-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-1560-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were carried out in accordance with the revised Animals (Scientific Procedures) Act 1986. Bone marrow-derived MSCs were obtained from 3H Biomedical who generated these cells with appropriate ethical approval ().","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}